UCSF Vision Correction Center competitors

Richard J. Liekweg is president and chief executive officer of BJC HealthCare, one of the nation’s largest nonprofit, integrated health care delivery organizations with over $6 billion in net revenues and more than 32,000 employees serving the greater St. Louis, southern Illinois and mid-Missouri regions. BJC is the largest provider of charity care, unreimbursed care and community benefit in Missouri, providing more than $800.8 million in financial assistance, education of health professionals, safety net services and community outreach programs. BJC’s patients have access to the latest advances in medical science and technology through a formal affiliation between BJC and the renowned Washington University School of Medicine, which consistently ranks among the top medical schools in the country. Barnes-Jewish Hospital and St. Louis Children’s Hospital rank among the most highly regarded teaching hospitals in the nation. BJC’s community and rural hospitals are also regularly recognized for excellence. Liekweg joined BJC HealthCare in 2009 as president of Barnes-Jewish Hospital and group president for BJC HealthCare. In 2015, Liekweg was promoted to executive vice president and subsequently president of BJC. He was named president and chief executive officer in January 2018. Before joining BJC, Liekweg served as chief executive officer and associate vice chancellor for the University of California, San Diego (UCSD) Medical Center from 2003-2009. Liekweg also spent more than 16 years at Duke University Health System, including serving as chief executive officer of Duke’s Durham Regional Hospital. He currently serves on the boards of several professional and community organizations including Vizient, Washington University, Missouri Hospital Association, Cortex, St. Louis Regional Health Commission, Greater St. Louis, Inc., BioSTL and Forest Park Forever. Liekweg holds a bachelor’s degree in economics from the University of Virginia and master’s degrees in health services administration and business administration, both from the University of Michigan.

Candace S Johnson is a Board at OmniSeq and Professor:Pharmaceutical Science at University at Buffalo Foundation, Inc and is based in Buffalo, New York. She has experience at University of Pittsburgh - PITT and has worked as President and CEO at Roswell Park, Professor of Pharmacology and Medicine at University of Pittsburgh School of Medicine, and Deputy Director of Basic Research at UPMC Hillman Cancer Center. Candace attended The Ohio State University between 1974 and 1977.

Bertram Lubin is a President and CEO at Children's Hospital & Research Center Oakland.

Laurie Hollis Glimcher is an American physician-scientist who was appointed president and CEO of Dana-Farber Cancer Institute in October 2016. She was elected a Member of the American Philosophical Society in 2019.

Jill Klar is a President and Chief Executive Officer/Chief Operating Officer at UNM Medical Group Inc; Chief Executive Officer, Chief Operating Officer at UNIVERSITY OF NEW MEXICO MEDICAL GROUP, INC.; and Chief Executive Officer, Chief Operating Officer at UNM and is based in Albuquerque, New Mexico. She has worked as Chief Operating Officer at DaVita Medical Group New Mexico; Director, Provider Affairs at Molina Healthcare of New Mexico, formerly Cimarron Health Plan, Inc.; and AVP, Provider Network Operations at Lovelace Health System. Jill works or has worked as Chairperson - 2016 Heart Ball at American Heart Association and Fundraising and community and philanthropic support at American Heart Association, March of Dimes, ABQ Business First - BizWomen Mentor, Lobo Club Board. She studied at UNM between 1990 and 1995.